By interacting with AGO2, they induce the assembly of the RNA-induced silencing complex (RISC), suppress the activation of tumor-associated signaling pathways, and thereby inhibit the proliferation and metastasis of BC cells [85,86]. This evidence concerns the gene AGO2 and neoplasm.